Background: Retinal vein occlusion (RVO) is a significant ocular condition characterized by the obstruction of the venous outflow from the retina. Its a common vascular disorder that can cause a number of visual impairments. Depending on the location and extent of the blockage, RVO can be classified into two types: central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO). Aims: Exploring diverse patient experiences, treatment outcomes, and associated vascular risk factors. Methods: This research adopts a retrospective observational approach, through an examination of patient populations, treatment outcomes, and vascular risk factor. The study included patients over the age of 18 who were diagnosed with RVO, possessing complete medical records and treatment data. Descriptive statistics were used for percentages, mean and standard deviation to find patient demographics and vascular risk factors. Inferentials were calculated using Wilcoxon Signed Ranks test to compare pre and post treatment visual acuity. Results: Conclusion: The study discovered that patients aged 50 and up with a history of hypertension were more likely to develop BRVO. The most prevalent type was BRVO, followed by CRVO. Patients with BRVO, no diabetes history, and under the age of 50 experienced the greatest improvement in visual acuity following treatment. No associations were found between age, gender, hypertension history, type of RVO, treatment, or affected eye. RVO is a serious ophthalmic condition characterized by occlusion in blood vessels from the retina. It can present with other complications like severe swelling, edema, and hemorrhage. RVO is prevalent in developed countries and it is common in developing countries. Retinal vein occlusion requires immediate therapy otherwise it may lead to loss of vision. With advances in ophthalmology, currently, there are many effective treatment options.